 | Up a level |
Kurch, L; Hasenclever, D; Kluge, R; Georgi, T; Tchavdarova, L; Golombeck, M; Sabri, O; Eggert, A; Brenner, W; Sykora, K W; Bengel, F M; Rossig, C; Körholz, D; Schäfers, M; Feuchtinger, T; Bartenstein, P; Ammann, Roland; Krause, T; Urban, C; Aigner, R; ... (2019). Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial. Pediatric blood & cancer, 66(3), e27539. Wiley-Liss 10.1002/pbc.27539
Klaeser, B; Spanjol, M; Krause, T (2012). [SPECT/CT diagnostics for skeletal infections]. Radiologe, 52(7), pp. 615-20. Berlin: Springer-Verlag 10.1007/s00117-011-2272-1
Dahdal, S; Andres, RH; Hewer, E; Reubi, JC; Klaeser, B; Aujesky, D; Seidel, U; Abbeel, S; Schmid, R; Tänzler, K; Aebersold, DM; Krause, T; Schmuecking, M (2012). A rare case of large spinal meningeoma with medistinal extensions and malignant behaviour, classifed histologically as benign. Theranositcs, Gallium-68 and other Radionuclides. A Pathway to Personalized Diagnosisi and Treatment
Schmuecking, M; Klaeser, B; Krause, T; Aebersold, D M (2012). Optimierung der Strahlentherapieplanung von Patienten mit inoperablen lokal fortgeschritten nicht-kleinzelligen Lungenkarzinomen (NSCLC) mittels 18F-FDG PET. Schweizer Krebsbulletin / Bulletin suisse du cancer, 32(2)(32(2)), pp. 112-114. Bellinzona: Istituto oncologico della Svizzera Italiana
Krause, T; Klaeser, B (2012). Radioisotopenbehandlung beim ossär metastasierten Prostatakarzinom. Info@Onkologie, 2(6), pp. 23-25. Erlenbach: Aerzteverlag medinfo AG
Dahdal, S; Andres, RH; Hewer, E; Reubi, JC; Klaeser, B; Aujesky, D; Seidel, U; Abbeel, S; Schmid, R; Tänzler, K; Aebersold, DM; Krause, T; Schmuecking, M (2011). Primary extracranial grade 1 meningeoma extending through the intervertebral foramina C7-T4 with an extensive mediastinal mass. In: PRRNT. Bad Berka: PRRNT
Schmücking, M.; Klaeser, B.; Krause, T; Aebersold, DM (2011). Molekulare Bildgebung mittels PET-CT: neue Potentiale. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 11(3), pp. 46-47. Basel: EMH Editores Medicorum Helveticorum
Klaeser, B; Mueller, MD; Schmid, RA; Guevara, C; Krause, T; Wiskirchen, J (2009). PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences. Immunoanalyse & biologie spécialisée(24), pp. 58-68. Issy-les-Moulineaux (F): Elsevier Masson
Johann, S; Klaeser, B; Krause, T; Mueller, MD (2008). Vergleich von klinischem Verlauf und rezidivfreiem Überleben nach Sentinellymphadenektomie vs kompletter inguinaler Lymphadenektomie bei Vulvakarzinom.
Johann, S; Klaeser, B; Krause, T; Mueller, MD (2008). Sentinellymphadenektomie beim Vulvakarzinom: Sicherheit und Morbidität im klinischen Alltag. Gynäkologisch-geburtshilfliche Rundschau(48), pp. 146-202. Basel: Karger
Netzer, P; Sendensky, A; Wissmeyer, M P; Baumeler, S; Batista, C; Scheurer, U; Krause, T; Reber, P; Brenneisen, R (2008). The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study. Alimentary pharmacology & therapeutics, 28(11-12), pp. 1334-41. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2008.03855.x
Warncke, SH; Mattei, A; Fuechsel, FG; Z'Brun, S; Krause, T; Studer, UE (2007). Detection rate and operating time for y-probe guided sentinel lymph node resection after injection of Technetium-99m-Nanocolloid into the prostate and without preoperative imaging. European urology, 52(1), pp. 126-133. Amsterdam: Elsevier 10.1016/j.eururo.2007.01.050
Vock, J; Jüngling, FD; Krause, T; Wissmeyer, M (2007). Muscular FDG uptake after chewing chewing gum in a patient with Hodgkin disease. Clinical nuclear medicine, 32(2), pp. 124-7. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/01.rlu.0000252337.14196.ed
Fuechsel, F G; Weidner, S; Krause, T (2006). Focal pelvic uptake in 18F-FDG PET due to a contraceptive device; a potential pitfall easily unmasked by PET-CT. Nuklearmedizin / Nuclear medicine, 45(4), N42-3. Stuttgart: Schattauer
Netzer, P; Wissmeyer, MP; Sendensky, A; Batista, C; Baumeler, S; Brenneisen, R; Krause, T; Reber, P; Gschossmann, JM; Scheurer, U (2006). The effect of naloxone-3-glucuronide (NX3G) on gastro-coecal transit time in healthy volunteers under morphine medication. Gastroenterology(130), A291-292. Philadelphia, Pa.: Elsevier
